ライフサイエンスコーパス: infection rate

1 etained original hardware had a 11.3% repeat infection rate.

2 ause of the unpredictable variability of the infection rate.

3 thin nonciliated cells despite a low initial infection rate.

4 neutropenia, although without an increase in infection rate.

5 tion did not reduce the 90-day sternal wound infection rate.

6 ases the inclusion size but has no effect on infection rate.

7 d key epidemiological quantities such as the infection rate.

8 central venous catheter-related bloodstream infection rate.

9 use) being performed, or a true increase in infection rate.

10 n other parameters such as the host-pathogen infection rate.

11 unlikely to account for such variation in CO infection rates.

12 oprevalences, in addition to those with high infection rates.

13 5% confidence intervals (95% CIs) to compare infection rates.

14 ention bundle compliance and changes in MDRO infection rates.

15 ta herbivory or P. syringae pv tomato DC3000 infection rates.

16 significant racial and ethnic disparities in infection rates.

17 Loss of MUC-16 was then correlated with infection rates.

18 nce of these HRS was not an indicator of low infection rates.

19 e agents as well as the potential for higher infection rates.

20 of magnitude larger than activation and new infection rates.

21 ings on medical devices to reduce nosocomial infection rates.

22 ntrations were not associated with increased infection rates.

23 us extinction, resulting in surprisingly low infection rates.

24 n CAR-dependent Ad types, despite equivalent infection rates.

25 utcomes of infants living in areas with high infection rates.

26 predominant genotype and the maintenance of infection rates.

27 e sex ratio was not associated with mosquito infection rates.

28 ll as semen itself, can markedly enhance HIV infection rates.

29 lity and may have decreased secondary fungal infection rates.

30 her than the N. gonorrhoeae and T. vaginalis infection rates.

31 envelope protein correlate with reduced HIV infection rates.

32 y predispose them to higher colonization and infection rates.

33 gambiae and Anopheles funestus survival and infection rates.

34 les [e.g., length of hospital stay (LOS) and infection rates].

35 orbidity (36.4% vs 27.3%, P = 0.3) and wound infection rates (14.5% vs 5.5%, P = 0.13).

36 ally for comparison of healthcare-associated infection rates across institutions.

37 asure the effect of the policy on changes in infection rates, adjusting for baseline trends.

38 The infection rate after cranial bone flap replacement range

39 s showed a significantly lower surgical site infection rate after laparoscopic surgery (OR = 0.19; 95

40 Both groups decreased infection rates after implementation and sustained these

41 was a statistically significant decrease in infection rates after intervention in 21 studies, with r

42 n of central catheter-associated bloodstream infection rates after the stepwise implementation of chl

43 ssion of mCherry and Luc are correlated with infection rate, allowing the monitoring of RSV multiplic

44 e was associated with a higher TV persistent infection rate among those receiving the single-dose tre

45 r, FcgammaRIIIa genotype was associated with infection rate among vaccinees (P = .035).

46 is is the first study to document annual HEV infection rates among "healthy" and very young to elderl

47 ose for both age groups, with much higher re-infection rates among children compared to adolescents a

48 ized driveline protocols, leading to reduced infection rates among MCS recipients.

49 HIV infection rates among men who have sex with men (MSM) in

50 pe DI was frequent and comparable to primary infection rates among MSM in San Diego; however, superin

51 ound no evidence that IVM reduced Plasmodium infection rates among surviving mosquitoes, the mosquito

52 The bloodstream infection rates among the patients at MNH (n=513) and LC

53 estimates of anal human papillomavirus (HPV) infection rates among young men who have sex with men (Y

54 severe sepsis are explained by both a higher infection rate and a higher risk of acute organ dysfunct

55 Results indicated that FLEs-Hd had 100% infection rate and a perfect vertical transmission in H.

56 This resulted in a decrease in the infection rate and a reduction in the accumulation of me

57 l) have been shown to beneficially influence infection rate and clinical outcomes in surgical patient

58 seasonal vaccination programme would affect infection rate and mortality.

59 dysregulation, which results in an increased infection rate and reduced effectiveness of vaccination.

60 in (a PG synthesis inhibitor) leads to lower infection rates and aberrant cell shapes, suggesting tha

61 effective in reducing healthcare-associated infection rates and are increasingly used to ensure the

62 pestis phoP-negative mutants achieved normal infection rates and bacterial loads in the flea midgut b

63 Using data on fishery landings, fish infection rates and consumption habits of the Spanish po

64 ated immune alterations associated with high infection rates and diminished protection following vacc

65 t Supporting behaviours were linked to lower infection rates and Envisioning change behaviours were l

66 t phage with relatively long lifetimes, high infection rates and large burst sizes; (ii) large, stabl

67 epilepticus; furthermore, it portends higher infection rates and longer hospitalizations.

68 hemodialysis because of lower thrombosis and infection rates and lower health care expenditures compa

69 evention strategies in an effort to decrease infection rates and morbidity due to Toxocara.

70 ients, offering an explanation for increased infection rates and possible long-term side effects asso

71 Overall infection rates and rates of RTI, skin and soft-tissue i

72 thod and two observed data streams, mosquito infection rates and reported human WNV cases.

73 Central catheter-associated bloodstream infection rates and safety outcomes (central catheter in

74 hat neutrophil dysfunction may underlie high infection rates and sepsis postburn; however, neutrophil

75 We calculated HIV infection rates and used logistic regression to identify

76 robustly reduced infarct volumes, decreased infection rate, and increased long-term survival of 2D2

77 Organ failure, infection rate, and mortality did not differ between gro

78 Viral load, its effect on infection rate, and the role of latently infected cells

79 and their impact on the patients' survival, infection rate, and use of dialysis were assessed.

80 diatric long-term care facilities, calculate infection rates, and identify risk factors for respirato

81 by fewer symptomatic cases of malaria, lower infection rates, and lower parasite densities compared t

82 of disease, the recent increase in reported infection rates, and the reproductive and economic conse

83 ed to have acute or chronic giardiasis, with infection rates approaching 90% in areas where Giardia i

84 LOS and infection rates are decreased in LVHR, but overall compl

85 HEV infection rates are dynamic in England and Wales, influe

86 Accurate forecasts of mosquito infection rates are generated before peak infection, and

87 e is controversy over whether osteoarticular infection rates are increasing or decreasing.

88 With current systems, infection rates are likely to decline without meaningful

89 expands, improved methods for risk-adjusting infection rates are needed.

90 Finally, we show that transmission and infection rates are not affected by sfRNA after intratho

91 This study tested the hypothesis that infection rates are the same for larval progeny derived

92 d organ system or site), the plausibility of infection (rated as none, possible, probable, or definit

93 scharge from hospital with an improvement in infection rates as well as 1 and 2-year survival rates.

94 Cumulative mortality or HIV infection rates at 18 months were 80 infants (13.9%, for

95 or hernia recurrence and postoperative wound infection rates at 24 months, and the EQ-5D and Short Fo

96 Infection rates at baseline ranged from 71% to 57%, but

97 sson regression modeling was used to compare infection rates before, during, and up to 18 months afte

98 The comparison of acquired infection rates between groups was adjusted for differen

99 There was no difference in infection rates between studies with low or high baselin

100 ce in complications, including urinary tract infection rates, between those using single or multi-use

101 nd parasitised RBCs, RBC age preference, RBC infection rate, burst size, and within-RBC interference.

102 ukoreduction tended to reduce the nosocomial infection rate but not significantly.

103 e coinoculation of BYDV-PAV lowered CYDV-RPV infection rate, but the reverse was not true.

104 iotic prophylaxis (AP) reduces surgical site infection rates, but prior data suggest variability in u

105 gery in obese patients reduces surgical site infection rate by 70%-80% compared with open surgery acr

106 Vertebrate consumers did not directly alter infection rates by this aphid-vectored pathogen group, b

107 Infection rate, cell viability, viral replication, and I

108 n feeding assays resulted in higher mosquito infection rates compared to membrane feeding assays (odd

109 ve control serum resulted in higher mosquito infection rates compared to own plasma (OR 1.92, 95% CI

110 icacy required for a drug to clear HCV), the infection-rate constant (beta), and the percentage of HC

111 e uncommon in children in the HAART era, and infection rates continue to be lower than those reported

112 By October to December 2007, the infection rate declined to 1.33 in the intervention grou

113 Forty-one before-after studies identified an infection rate decrease (OR, 0.39 [95% CI, .33-.46]; P <

114 The wound infection rate did not differ significantly across the 3

115 ecause of its high infection and hematologic infection rate, did not further improve outcome.

116 Adverse events, including secondary infection rates, did not differ between study groups.

117 Infection rates do not decline as expected in some commu

118 10(-8) day(-1); the percent reduction of the infection rate due to the presence of virus-specific ant

119 Stage-specific infection rate estimates from cases hospitalized before

120 The infection rate for studies that used cytomegalovirus DNA

121 Because the observed infection rates for each group were so low, this apparen

122 ce of antiviral antibodies agreed with known infection rates for the corresponding virus based on epi

123 lity, multiple organ failure, and nosocomial infection rates for the entire cohort (n = 1,036) were 2

124 ulted in a sustained reduction in the severe infection rate from 1.17 events per person-year to 0.17

125 easure predicted a decrease in postoperative infection rates from 11.5 to 5.3 per 1000 discharges (ad

126 easure predicted a decrease in postoperative infection rates from 14.2 to 6.8 per 1000 discharges (ad

127 The main outcome measure was change in infection rates from baseline to year 3.

128 ssion model showed a significant decrease in infection rates from baseline, with incidence-rate ratio

129 rom the initial case series in Hong Kong and infection rates from hospitalizations in Singapore, we d

130 t allows us to estimate the heterogeneity of infection rates from the relationship between rates of i

131 The CIED infection rate has increased at a time of increased devi

132 Increased infection rates have been reported in ruxolitinib-treate

133 Klebsiella pneumonia infection rates have increased dramatically.

134 tic antibiotic regimens reduce postoperative infection rates, improved instrumentation and diathermy

135 e sepsis rate was explained by both a higher infection rate in black patients (47.3; 95% CI, 47.1-47.

136 The infection rate in both the 15 mg twice daily group and t

137 these data regarding both the increased GAS infection rate in children and the development of protec

138 omastigotes caused a higher initial in vitro infection rate in human or murine macrophages than untre

139 rse postoperative outcomes including overall infection rate in LT patients, a relationship between in

140 orrhoeae infections, while the M. genitalium infection rate in males was significantly higher than th

141 n immunoglobulin levels, normal B cells, and infection rate in patients with CLL treated with single-

142 association between FcgammaRIIa genotype and infection rate in vaccinees or placebo recipients.

143 Hospitals with high ARB infection rates in 2005 had an excess burden of BSI of 2

144 gher infectious doses are required to obtain infection rates in animals similar to those of B. abortu

145 low cytometric analysis to directly quantify infection rates in bronchial epithelial tissues.

146 are highly context specific, as they reduce infection rates in elective surgery, but possibly increa

147 to any measures of horizontal spread (e.g., infection rates in epidemiology) that are based on simpl

148 duced V3 Abs are associated with reduced HIV infection rates in humans and affect the nature of trans

149 Mosquito infection rates in membrane feeding assays and direct sk

150 When chronic infection rates in mice deficient in the Th2 cytokine in

151 DC dysfunction may result in increased infection rates in ruxolitinib-treated patients.

152 arget for interventions designed to decrease infection rates in smokers and possibly in individuals w

153 gp120 envelope (Env) correlated with reduced infection rates in studies of HIV, simian-human immunode

154 icacy of the vaccine and the increased HIV-1 infection rates in subgroups of vaccine recipients are b

155 eby enhancing immune function and decreasing infection rates in the elderly.

156 ears to be associated with lower disease and infection rates in the long term, trachoma and C. tracho

157 ion in a ZIP code area with male urethral GC infection rates in the top quartile of Washington State

158 al viral load, pup mortality, and congenital infection rates in the vaccine and control groups were c

159 ract infections had any measurable effect on infection rates in U.S. hospitals.

160 hospital, and ventilator days; bleeding and infection rates; incidence of reperfusion lung injury; a

161 Key epidemiological parameters including the infection rate, incubation period and scale of dispersal

162 was predicted by recent hospital C difficile infection rates, introduction of mandatory surveillance

163 disease from spreading, although only if the infection rate is below a threshold.

164 out acute infection up to the set-point, the infection rate is higher in ramp-up plasma virus recipie

165 ection prevention programs, and reporting of infection rates is increasingly required.

166 residual spraying or a vaccine which reduces infection rates is just before the high season.

167 ensitive testing methods, or higher exposure/infection rates is unknown.

168 Infection rates, knowledge about soil-transmitted helmin

169 ts per 1,000 drainage days (drain-associated infection rate), length of ICU stay, Glasgow Outcome Sca

170 showed that IIT reduced long-term mortality, infection rates, length of stay, or the need for renal r

171 Safety included analysis of infection rates, line malfunctions, temporary hospitaliz

172 nd decreases in human immunodeficiency virus infection rates, little is known about the factors assoc

173 diction Model scores, have higher nosocomial infection rates, longer intensive care unit and hospital

174 time, web-based estimates of local influenza infection rates makes this type of quantitative forecast

175 by host genetics, and, depending on relative infection rates, may further contribute to the complexit

176 culture were determined, as were the midgut infection rates (MIR) in A. aegypti mosquitoes.

177 en, but it does not significantly change the infection rate, mortality, length of stay, or measures o

178 Positive clusters had a 16.0% infection rate, negative clusters 1.1%.

179 adjusted central line-associated bloodstream infection rate of 0.9 (95% confidence interval 0.5-1.5)/

180 895 (21.5%) who received antibiotics had an infection rate of 1.7% compared with 0.7% in the 3261 (7

181 was obtained showing a Class I surgical site infection rate of 1.78%, Class II of 2.82% (total surgic

182 adjusted central line-associated bloodstream infection rate of 1.8 (95% confidence interval 0.9-3.3)/

183 However, an infection rate of 12.2% has been reported following remo

184 By contrast, the IFNGRA suggested an infection rate of 16/75 (22%).

185 3901 (73.5%) with complete compliance had an infection rate of 3.0%, whereas 1408 (26.5%) who were no

186 s 1408 (26.5%) who were not compliant had an infection rate of 4.3% (adjusted relative risk: 0.7; 95%

187 The model estimates a mean infection rate of 76% among recipients who receive one u

188 is is in contrast to our previously reported infection rate of about 5% among Bangladeshi villagers.

189 amination, which directly contributes to the infection rate of hosts for the between-host sub-system.

190 ved viruses were identified, representing an infection rate of nearly 5%.

191 S incidence with capture rate and hantavirus infection rate of rodent species in Qingdao City, China.

192 idence to rodent capture rate and hantavirus infection rate of rodents were analyzed statistically.

193 ius and Rattus norvegicus and the hantavirus infection rate of these rodent species in the field or r

194 strains, the high prevalence and subclinical infection rate of these viruses in pigs raise questions

195 dian central catheter-associated bloodstream infection rate of zero across >100 intensive care units

196 significant among studies reporting baseline infection rates of <1.15 per 1000 catheter-days, and stu

197 75.4% (two-thirds of these studies reported infection rates of 10% or less).

198 acquisition fed produced larval progeny with infection rates of 12% to 48%.

199 , as demonstrated by microscopy and PCR, had infection rates of 22% to 30% and transmitted B. bovis d

200 idespread, with seven field sites exhibiting infection rates of 30% or greater.

201 and estimate the parameters representing the infection rates of anomalous deviations from normal tren

202 such antibodies were associated with reduced infection rates of HIV, SIV, and SHIV.

203 There was no significant difference in infection rates of larval progeny, implying that the ris

204 ionship between kinete levels in females and infection rates of larval progeny.

205 Furthermore, infection rates of the six host species in the field wer

206 Infection rates of Trypanosoma brucei gambiense in tsets

207 9 pandemic of influenza A virus subtype H1N1 infection, rates of hospitalizations due to laboratory-c

208 (>10 mg/kg) were associated with a lower CMV infection rate on univariate analysis.

209 rder to understand parasite growth rates and infection rates over time.

210 timicrobial resistance (AMR) on regional AMR infection rates over time.

211 demonstrates a steady decline in bloodstream infection rates over time.

212 The authors calculated HEV infection rates, over an 18-month interval between 2003

213 was also associated with a 50% reduction in infection rate (P = .003).

214 ls had irreversible atelectasis, higher lung infection rates (P<0.0001) and BAL neutrophil percentage

215 Central venous access device infection rate per 1000 line days decreased from 8.49 to

216 The acute serious bacterial infection rate per subject-year for IGHy was low (0.025;

217 Infection rates per 100 births were 3.61 (CI, 0.75 to 10

218 onfidence interval, 7 to 73) on the basis of infection rates per 100 person-years.

219 Overall infection rates per subject-year were 2.97 for IGHy and

220 Salmonella cells present high infection rates, persistence over inauspicious condition

221 Major epidemics in the meningitis belt have infection rates ranging from 100 to 800 per 100 000 popu

222 CoV infections were identified, with annual infection rates ranging from 2.8% to 26% in prospective

223 12 months had an increased rate of incident infection (rate ratio [RR], 5.1; 95% CI, 1.3-19.6]).

224 sease (rate ratio, 3.7; 95% CI, 3.2 to 4.2), infection (rate ratio, 4.7; 95% CI, 4.0 to 5.5), acute d

225 pplementation reduced the prevalence of EPEC infections (rate ratio [RR], 0.52 [95% confidence interv

226 ementation reduced the prevalence of NoV GII infections (rate ratio [RR], 0.60 [95% confidence interv

227 interrupted time series studies revealed an infection rate reduction 3 months postintervention (OR,

228 Secondary bloodstream infection rates remained unchanged throughout the observ

229 der on multiple organ failure and nosocomial infection rates remains significant in both premenopausa

230 To test whether these heterogeneous infection rates result from evolved differences in immun

231 Relationships between infection rates, self-reported compliance, and audits we

232 ring 2008-2012 was contact lens use, and the infection rate significantly increased from 40.7% to 52.

233 Moreover, low-risk VV vaccinees had infection rates similar to individuals with high behavio

234 accinated low-risk VV subjects had a greater infection rate than low-risk VV placebo recipients (HR =

235 hool-aged children have substantially higher infection rates than adults.

236 ll neighborhood enables the simulation of an infection rate that is correlated to the viral load.

237 However, the reduced infection rate that resulted from the vaccine used in th

238 In the context of increasing Chlamydia infection rates, the reproductive complications of Chlam

239 hesizing the effects of climate variables on infection rates, though pathosystem-specific characteris

240 -infections are frequent, possibly affecting infection rates through competition or facilitation.

241 There was no difference in wound infection rate, time to regular diet, length of hospital

242 Applying the Quest HCV infection rate to annual live births from 2011 to 2014 r

243 The control group also reduced infection rates to <1/1,000 central line days (a 69% red

244 hetic implant infection to determine chronic infection rates, Treg cell frequencies, and local cytoki

245 racteristics (e.g., breast milk substitutes, infection rates, underweight, and pubertal timing) diffe

246 t, the donor-risk-index had no impact on the infection rate, use of dialysis or survival.

247 ndardize and optimize the assessment of KSHV infection rates using a combination of established and n

248 et cell types for head-to-head comparison of infection rates, viral output, and cytokine production u

249 ty to VSV infection as evidenced by elevated infection rates, virus replication in multiple tissue ty

250 The overall catheter-related bloodstream infection rate was 0.2 per 1,000 catheter days.

251 The infant infection rate was 0.75 per 100 births from 1997 to 2010

252 The infection rate was 1.4%, 1.5%, and 2.0% for single, dual

253 -Hispanic whites (P < .001), while the HSV-1 infection rate was 1.7 times higher in non-Hispanic whit

254 The posttransfusion nosocomial infection rate was 14.3% in 428 evaluable patients, sign

255 8% and 10.5% (p = 0.02) and drain-associated infection rate was 18 and 7.1, respectively (p = 0.0001)

256 The overall 1-year device-related infection rate was 2.4% (16 of 659).

257 The HSV-2 infection rate was 2.6 times higher in non-Hispanic blac

258 The estimated infection rate was 230 (95% CI, 175-293) infections/1000

259 The infection rate was 4.1% versus 3.6% in the TV-ICD groups

260 The overall infection rate was 5.3 infections per 1000 resident-days

261 The overall postoperative infection rate was 8.0%.

262 Incident bloodstream infection rate was 9.6 and 8.4 per 1000 hospital days in

263 adjusted central line-associated bloodstream infection rate was calculated for these cumulated line d

264 Among cohort members (n = 173), the Ad14 infection rate was high (50%).

265 ge of neuronal and non-neuronal tropism, the infection rate was highest in intermediate progenitor ce

266 Thus, the repeat infection rate was low (1.8%) in those who were reimplan

267 The infection rate was not statistically different on univar

268 The infection rate was significantly higher in the ASB group

269 The difference in infection rates was because of lower bacterial (32% vs 4

270 The 6-month infection rates were 1.4% (95% confidence interval, 0.7

271 Very low-birth-weight infant infection rates were 16.4% in 2008 and 13.9% in 2009.

272 f 414 patients showed that the postoperative infection rates were 17% (35 of 207) in the nontreatment

273 Thirty-day overall and organ/space infection rates were 17.4% (175) and 8.5% (86).

274 37%) or B (23%) (P < 0.001); cytomegalovirus infection rates were 35%, 20% and 23%, respectively (P =

275 The 7-month HIV infection rates were 5.6% (32 infants in the formula-fed

276 e vaccine did not prevent HIV-1 acquisition: infection rates were 6.7% in 3598 vaccinees and 7.0% in

277 Surgical site infection rates were also higher among patients with an

278 Persistent TV infection rates were compared for women on ART at baseli

279 Catheter infection rates were determined per 1,000 catheter days

280 luated over 180 days; immunogenicity and RSV infection rates were evaluated over 112 days.

281 Infection rates were lower in group B compared with grou

282 Infection rates were lower in those who had been treated

283 ) were able to infect neutrophils, while the infection rates were lower than 29%, suggesting that C.

284 Hospital-acquired infection rates were not different between the two perio

285 Estimates of enteric pathogen infection rates were obtained from case-control studies

286 Higher infection rates were recorded in the >2-year and the 1-

287 Posttransplant infection rates were recorded.

288 While ADE infection rates were remarkably consistent in monocytes

289 Surgical site infection rates were significantly higher among people w

290 However, infection rates were significantly lower than those repo

291 Wound infection rates were similar in both groups.

292 Overall oral SIV infection rates were similar in the gingivitis-induced a

293 Infection rates were similar.

294 rs, there were no differences in trachoma or infection rates, when comparing new residents who came a

295 SR as a VAD indicator may depend on infection rates, which should be taken into consideratio

296 uctuations indicative of seasonal forcing of infection rates, which was likely driven by multiple env

297 Antibacterial and G-CSF prophylaxis reduced infection rates while mandatory hospitalization did not

298 for probable viral infections, and reducing infection rates will help preserve the antibiotics we ha

299 Infection rates with F. necrophorum, group A streptococc

300 We assessed variation in bloodstream infection rates within and between PICUs over a 10-year